Abstract:OBJECTIVETo investigate the mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy (DCM) by valsartan.METHODSForty male wistar rats were randomly divided into 3 groups: DCM group, n = 16, fed with high-fat diet for 4 weeks and injected intraperitoneally with streptozocin (STZ) once to induce hyperglycemia so as to construct a DCM model, and then perfused into the stomach with normal saline; valsartan group, n = 16, to be constructed into DCM model and then perfused into the stomach with valsartan once daily; and control group (n = 8, fed with normal food and perfused into the stomach with normal saline. Four weeks after feeding (i.e., before injection of STZ), 1 week after STZ injection, and by the end of experiment after 12-hour fasting samples of venous blood were collected to detect the contents of triglyceride and fasting blood-glucose and insulin; by the end of experiment miniature cardiac catheter was inserted into the left ventricle to conduct hemodynamic examination. Then myocardium tissues were collected, collagen content was detected by Masson staining, real-time RT-PCR was used to detect the mRNA expression of thrombospondin (TSP)-1 and tumor growth factor (TGF)-beta(1) mRNA, expression, and Western blotting was used to detect the protein expression of TSP-1, active TGF-beta(1) (A-TGF-beta(1)) and latent TGF-beta(1) (L-TGF-beta(1)).RESULTSBy the end of the experiment, the body weights, and insulin sensitivity index were significantly lower and fasting blood-glucose, and serum triglyceride and cholesterol were significantly higher in the DCM group and valsartan group in comparison with those in the control group (all P < 0.01), however, there was no significant differences in fasting insulin among these 3 groups. The values of left ventricular systolic pressure (LVSP) and +/- dp/dt(max) were significantly lower and left ventricular end diastolic pressure were significantly higher in the DCM group in comparison with the control group (all P < 0.01). The LVSP and -dp/dt(max) were significantly higher and LVEDP was significantly lower in the valsartan group than in the DCM group (all P < 0.05). The LVEDP was significantly higher and -dp/dt(max) was significantly lower in the valsartan group than in the control group. Electron microscopy showed the distribution of a great amount of collagen in the myocardial interstitial tissue. The collagen content of the DCM group was 17 +/- 3, significantly higher than that of the control group (11 +/- 3, P < 0.05), and the collagen content of the valsartan group was 13 +/- 3, significantly lower than that of the DCM group (P < 0.05). The mRNA expression of TSP-1 and that of TGF-beta(1) were significant higher in the DCM group than in the control group (both P < 0.05), and were significantly lower in the valsartan group than in the DCM group (both P < 0.05); however, the TGF-beta(1) mRNA expression in the valsartan group was significantly higher in the valsartan group than in the control group (P < 0.05). The values of protein expression of TSP-1, A-TGF-beta(1) and L-TGF-beta(1) were all significantly higher in the DCM group than in the control group (all P < 0.05), and the values of protein expression of TSP-1 and A-TGF-beta(1) in the valsartan group were both significantly lower than those in the DCM group (both P < 0.05), however, there was no significant difference in the protein expression of L-TGF-beta(1) between the valsartan group and DCM group.CONCLUSIONValsartan amelioorates myocardial interstitial fibrosis in DCM via TSP-1/TGF-beta(1) signaling pathway.

Valsartan Protects Against Er Stress-Induced Myocardial Apoptosis Via Chop/Puma Signaling Pathway in Streptozotocin-Induced Diabetic Rats

Combined Treatment with Ultrasound-Targeted Microbubble Destruction Technique and NM-aFGF-loaded PEG-nanoliposomes Protects Against Diabetic Cardiomyopathy-Induced Oxidative Stress by Activating the AKT/GSK-3β1/Nrf-2 Pathway

THE MYOCARDIAL PROTECTIVE EFFECTS OF PUERARIN ON STZ-INDUCED DIABETIC RATS

Irbesartan Ameliorates Diabetic Cardiomyopathy by Regulating Protein Kinase D and ER Stress Activation in a Type 2 Diabetes Rat Model

Interventional Effect of Valsartan on Expression of Inducible Camp Early Repressor and Phosphodiesterase 3A in Rats after Myocardial Infarction.

Influence of Valsartan on Myocardial Apoptosis in Spontaneously Hypertensive Rats.

Effect and Mechanism of Sacubitril/valsartan on Ventricular Remodeling in STZ induced Diabetic Cardiomyopathy Rats

Effect And Mechanism Of Sacubitril/Valsartan On Ventricular Remodeling In Diabetic Rats With Cardiomyopathy

LCZ696 Protects against Diabetic Cardiomyopathy-Induced Myocardial Inflammation, ER Stress, and Apoptosis through Inhibiting AGEs/NF-κB and PERK/CHOP Signaling Pathways

[Mechanism of Reversion of Myocardial Interstitial Fibrosis in Diabetic Cardiomyopathy by Valsartan].

Cardioprotective Effects of Telmisartan on Diabetic Cardiomyopathy in Rats

Allisartan isoproxil attenuates oxidative stress and inflammation through the SIRT1/Nrf2/NF-κB signalling pathway in diabetic cardiomyopathy rats

Chronic Resveratrol Treatment Improves Cardiac Function In A Rat Model Of Diabetic Cardiomyopathy Via Attenuation Of Mitochondrial Injury And Myocardial Apoptosis

Valsartan Improves Cardiac Function in Mice with Diabetes Mellitus by CaMKII/AngII.

Effect of Valsartan on the Expressions of Bcl-2 and Bax Proteins in Myocardium of Spontaneously Hypertensive Rats

Data on effect of Sacubitril/valsartan on cardiac Remodelling in diabetic Cardiomyopathy rats

Effect of valsartan on cardiac senescence and apoptosis in a rat model of cardiotoxicity

Losartan Attenuates Myocardial Endothelial-To-Mesenchymal Transition in Spontaneous Hypertensive Rats Via Inhibiting TGF-β/Smad Signaling

Dapagliflozin attenuates pressure overload-induced myocardial remodeling in mice via activating SIRT1 and inhibiting endoplasmic reticulum stress

Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats

[Effects of Valsartan on Sarcoplasmic Reticulum Calcium Adenosine Triphosphatase, Protein Kinase A and Protein Phosphatase 1 Alpha in a Rabbit Model of Heart Failure].